Ranbaxy Laboratories' tentative approvals for its generic versions of digestive disorder drug Nexium and antiviral Valcyte along with 180-days marketing exclusivity stands canceled following a US court decision.
from Zee News :Zee News - Health http://bit.ly/1Cool8a via Health News Daily
from Zee News :Zee News - Health http://bit.ly/1Cool8a via Health News Daily
No comments:
Post a Comment